Home Biosimilar Antibodies Metabolism PCSK9 antibody Ongericimab (Anti-PCSK9) For research use only.
Not for use in humans.

Ongericimab (Anti-PCSK9)

Synonyms: JS002

Ongericimab (Anti-PCSK9) is a humanized monoclonal antibody targeting PCSK9. It has lipid-lowering efficacy and can be used in research of hypercholesteremia and hyperlipidemia. MW :143.04 KD.

Ongericimab (Anti-PCSK9)

Purity & Quality Control

Choose Selective PCSK9 Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Ongericimab (Anti-PCSK9) is a humanized monoclonal antibody targeting PCSK9. It has lipid-lowering efficacy and can be used in research of hypercholesteremia and hyperlipidemia. MW :143.04 KD.

Product Details

CAS No. 2145096-91-7
Molecular Weight 143.04
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ongericimab (Anti-PCSK9) | Ongericimab (Anti-PCSK9) supplier | purchase Ongericimab (Anti-PCSK9) | Ongericimab (Anti-PCSK9) cost | Ongericimab (Anti-PCSK9) manufacturer | order Ongericimab (Anti-PCSK9) | Ongericimab (Anti-PCSK9) distributor